Compounds > sulofenur
Page last updated: 2024-08-24

sulofenur and Colonic Neoplasms

sulofenur has been researched along with Colonic Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, SH; Kang, JS; Kim, HM; Kim, NS; Lee, KC; Sharma, VK; Subramanian, S; Thanigaimalai, P1
Cheshire, PJ; Grindey, GB; Houghton, JA; Houghton, PJ; Lutz, L; Myers, L; Toth, J1
Berezesky, IK; Boder, GB; Jain, PT; Phelps, PC; Trump, BF1
Houghton, JA; Houghton, PJ1
Bebensee, S; Dwivedi, C; Erickson, AK; Gilkerson, KK; Guan, X; Hoffman, BN; McFarland, DC; Pellegrini, J1
Bailey, FC; Germain, GS; Grindey, GB; Houghton, JA; Houghton, PJ; Witt, BC1

Reviews

1 review(s) available for sulofenur and Colonic Neoplasms

ArticleYear
Antitumor diarylsulfonylureas: novel agents with unfulfilled promise.
    Investigational new drugs, 1996, Volume: 14, Issue:3

    Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Agents; Benzofurans; Child; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Drug Resistance, Multiple; Humans; Phenylurea Compounds; Sulfonylurea Compounds; Transplantation, Heterologous

1996

Other Studies

5 other study(ies) available for sulofenur and Colonic Neoplasms

ArticleYear
Structure--activity relationship studies of novel arylsulfonylimidazolidinones for their anticancer activity.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:8

    Topics: Animals; Antineoplastic Agents; Arylsulfonates; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Hydrophobic and Hydrophilic Interactions; Imidazolidines; Lung Neoplasms; Mice; Mice, Nude; Molecular Conformation; Neoplasm Transplantation; Ovarian Neoplasms; Structure-Activity Relationship

2011
Efficacy of sulofenur and a second generation diarylsulfonylurea, N-[5-(2,3-dihydrobenzofuryl)sulfonyl]-N'-(3,4-dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenografts.
    Anti-cancer drugs, 1995, Volume: 6, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Benzofurans; Colonic Neoplasms; Female; Humans; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Phenylurea Compounds; Sulfonylurea Compounds; Transplantation, Heterologous

1995
Sulofenur cytotoxicity and changes in cytosolic calcium and mitochondrial membrane potential in human colon adenocarcinoma cell lines.
    Cancer letters, 1995, Jan-06, Volume: 88, Issue:1

    Topics: Adenocarcinoma; Calcium; Cell Death; Cell Survival; Colonic Neoplasms; Cytosol; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Membrane Potentials; Microscopy, Electron; Mitochondria; Sulfonylurea Compounds; Tumor Cells, Cultured

1995
Glutathione and mercapturic acid conjugates of sulofenur and their activity against a human colon cancer cell line.
    Drug metabolism and disposition: the biological fate of chemicals, 2002, Volume: 30, Issue:3

    Topics: Acetylcysteine; Animals; Antineoplastic Agents; Bile; Cell Division; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cysteine; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Glutathione; Glutathione Reductase; Humans; Magnetic Resonance Spectroscopy; Male; Protein Binding; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine; Sulfonylurea Compounds; Tumor Cells, Cultured

2002
N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.
    Cancer research, 1990, Jan-15, Volume: 50, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Blood Physiological Phenomena; Cell Division; Cell Survival; Colonic Neoplasms; Culture Media; Humans; Serum Albumin; Sulfonylurea Compounds; Tumor Cells, Cultured

1990